Optimer Said to Draw Takeover Interest From GlaxoDavid Welch, Jeffrey McCracken and Drew Armstrong
Optimer Pharmaceuticals Inc., the antibiotics maker that’s weighing a sale, drew interest from drugmakers including GlaxoSmithKline Plc and Japan’s Astellas Pharma Inc., said two people familiar with the matter. The shares gained the most in more than four years.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.